Round Up Weed Killer

The Supreme Court of the United States has agreed to review a legal appeal filed by Bayer, the German company that owns Monsanto and RoundUp.

The Court has not made a decision and has not ruled against people bringing RoundUp claims. This review involves a narrow legal issue and does not decide whether RoundUp causes cancer or whether individual claims are valid.

What this means

• Your case has not been dismissed.
• Your rights have not changed.
• Many courts may proceed cautiously for a period of time while waiting for guidance.

This may affect timing, but it does not end cases or stop legal work from continuing.

What has not changed

• RoundUp lawsuits are still active nationwide.
• Prior verdicts and settlements remain in place.

Our firm continues to monitor developments closely and prepare cases for the next phase of litigation.

If you have questions about your case or believe a loved one may qualify for a claim, we encourage you to contact us directly on the RoundUp Hotline (205) 659-4379.

Many clients are wondering how long it may take to resolve their cases, but evidence is growing that the tide is turning in favor of plaintiffs. Juries in state court have recently awarded over $4 billion in damages to Round Up victims. These victories are increasing the pressure on Bayer, the parent company of the product, to reach a settlement with all victims.

A Georgia jury stunned Bayer on Friday, March 24, 2025, ordering the company to pay $2.1 billion in damages to Mr. John Barnes. Barnes developed non-Hodgkin’s lymphoma after using Roundup for two decades at his home. His purchases were well-documented at Home Depot from 1999 through 2019. In March of 2020, he was diagnosed with NHL, a life-altering condition that research has linked to prolonged exposure to glyphosate.

The verdict includes $65 million in compensatory damages and a devastating $2 billion in punitive damages. This throws cold water on Bayer’s refusal to take responsibility for the dangers of their product.

After the verdict, Bayer’s stock plummeted nearly 9% in early trading, adding to the company’s stock price decline of over 70% since purchasing Monsanto.

Financial pressure on Bayer continues to build. 60,000 Roundup lawsuits remain to be litigated, meanwhile, Bayer has set aside only $6 billion for future settlements. The March 24 Georgia verdict makes it clear that the amount will be insufficient.

The $2 billion award may prove to be the linchpin that moves Bayer to consider group settlements. Bayer CEO Bill Anderson will face increasing pressure to bring closure to the lawsuits as state verdicts continue to mount.